Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4(+) T Cell Responses

Given the current coronavirus disease 2019 (COVID-19) pandemic, coinfection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) is a major concern for public health. However, the immunopathogenic events occurring with coinfections of SARS-CoV-2 and IAV remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun-Ha, Nguyen, Thi-Quyen, Casel, Mark Anthony B., Rollon, Rare, Kim, Se-Mi, Kim, Young-Il, Yu, Kwang-Min, Jang, Seung-Gyu, Yang, Jihyun, Poo, Haryoung, Jung, Jae U., Choi, Young Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Pathogenesis and Immunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941868/
https://www.ncbi.nlm.nih.gov/pubmed/35107382
http://dx.doi.org/10.1128/jvi.01873-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941868/
https://www.ncbi.nlm.nih.gov/pubmed/35107382
http://dx.doi.org/10.1128/jvi.01873-21

Ejemplares similares